Axsome Therapeutics Company Profile
25 Broadway
New York NY 10004
212-332-3241
www.axsome.com
Industry: Biotechnology
Sector: Healthcare

Description
Axsome Therapeutics, Inc., a clinical stage biopharmaceutical company, develops therapies for the management and treatment of central nervous system disorders. Its product candidates include AXS-02, which is in Phase III trial for the treatment of complex regional pain syndrome, knee osteoarthritis, and chronic low back pain; and AXS-05 that is in Phase III trial for the treatment of resistant depression and agitation in patients with Alzheimer's disease. The company is also developing AXS-06 for the treatment of chronic pain disorders. Axsome Therapeutics, Inc. was founded in 2012 and is based in New York, New York.
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.